These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 198045)

  • 1. Effect of heterologous antiplatelet antibody on human platelets: a new pathway to platelet alteration.
    Colman RW; Kuchibhotla J; Schreiber AD
    Blood; 1977 Oct; 50(4):575-85. PubMed ID: 198045
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial biochemical responses of platelets to stimulation.
    Mills DC
    Ciba Found Symp; 1975; 35():153-73. PubMed ID: 179766
    [No Abstract]   [Full Text] [Related]  

  • 3. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
    Feinstein MB; Fraser C
    J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
    Johnson GJ; Rao GH; Leis LA; White JG
    Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura.
    Lian EC; Savaraj N
    Blood; 1981 Aug; 58(2):354-9. PubMed ID: 6264998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of adenosine disphosphate by human platelet membrane.
    Nachman RL
    Ciba Found Symp; 1975; 35():23-46. PubMed ID: 179768
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of heterologous antibody on human platelets.
    Colman RW; Schreiber AD
    Blood; 1976 Jul; 48(1):119-31. PubMed ID: 947400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of platelet membrane antibodies on aggregation and release.
    Kaplan KL; Nachman RL
    Br J Haematol; 1974 Dec; 28(4):551-60. PubMed ID: 4477019
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
    Holmsen H; Setkowsky CA; Day HJ
    Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
    Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
    Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme activities on the platelet surface in relation to the action of adenosine diphosphate.
    Mustard JF; Packham MA; Perry DW; Guccione MA; Kinlough-Rathbone RL
    Ciba Found Symp; 1975; 35():47-75. PubMed ID: 179770
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13,14-dehydro PGI2 methyl ester.
    Malmsten C; Claesson HE; Fried J
    Prostaglandins Med; 1980 Jun; 4(6):453-63. PubMed ID: 6251494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
    Reches A; Eldor A; Salomon Y
    Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.